Literature DB >> 1185168

Effects of low doses of catecholamine receptor agonists on exploration in mice.

U Strömbom.   

Abstract

Female mice were given 0.025--0.8 mg/kg of the dopamine and noradrenaline receptor agonists apomorphine and clonidine, respectively, and the effect on explorative behaviour of these drugs was tested in a Y-shaped runway for three minutes. Saline-treated controls displayed a stable exploratory behaviour, declining during the time period measured. The decline probably reflects adaptation to the new environment. Apomorphine depressed the activity, but the configuration of the time curve was the same as in controls. Clonidine also depressed the exploratory activity and further appeared to break the pattern of adaptation, the activity in clonidine-treated mice being low from the beginning. The higher doses of the drugs, alone or in combination, caused a pronounced suppression of the exploration. These mice were observed for ten minutes, under which period their exploration of the runway was not increased, as compared with the first three minutes. The smaller doses used are not known to cause functionally measureable activation of postsynaptic catecholamine receptors. On the other hand these doses are known as cause inhibition of firing in the respective presynaptic neurons and also inhibition of synthesis of the respective transmitter. Thus the present findings are interpreted to be due to presynaptic inhibition of the respective neurons. Clonidine caused a more pronounced inhibition of the exploration than apomorphine, suggesting nordrenaline to be of particular importance for exploratory behaviour.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1185168     DOI: 10.1007/bf01670131

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  14 in total

1.  Inhibition of both noradrenergic and serotonergic neurons in brain by the alpha-adrenergic agonist clonidine.

Authors:  T H Svensson; B S Bunney; G K Aghajanian
Journal:  Brain Res       Date:  1975-07-11       Impact factor: 3.252

2.  Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity.

Authors:  W Kehr; A Carlsson; M Lindqvist; T Magnusson; C Atack
Journal:  J Pharm Pharmacol       Date:  1972-09       Impact factor: 3.765

3.  On the role of central noradrenaline in the regulation of motor activity and body temperature in the mouse.

Authors:  T H Svensson
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

4.  Comparison of effects of L-dopa, amphetamine and apomorphine on firing rate of rat dopaminergic neurones.

Authors:  B S Bunney; G K Aghajanian; R H Roth
Journal:  Nat New Biol       Date:  1973-09-26

Review 5.  Mode of action of psychomotor stimulant drugs.

Authors:  J M Van Rossum
Journal:  Int Rev Neurobiol       Date:  1970       Impact factor: 3.230

6.  Dopamine and noradrenaline receptor stimulation: reversal of reserpine-induced suppression of motor activity.

Authors:  N E Andén; U Strömbom; T H Svensson
Journal:  Psychopharmacologia       Date:  1973

7.  [Pharmacological effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride, a new, antihypertensive substance].

Authors:  W Hoefke; W Kobinger
Journal:  Arzneimittelforschung       Date:  1966-08

8.  Behavioural and biochemical effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155) on the central nervous system.

Authors:  R Laverty; K M Taylor
Journal:  Br J Pharmacol       Date:  1969-02       Impact factor: 8.739

Review 9.  Dopamine (3-hydroxytyramine) and brain function.

Authors:  O Hornykiewicz
Journal:  Pharmacol Rev       Date:  1966-06       Impact factor: 25.468

10.  Effects of phenoxybenzamine, aceperone and clonidine on the level of 3-methoxy-4-hydroxyphenylglycol (MOPEG) in rat brain.

Authors:  C Braestrup
Journal:  J Pharm Pharmacol       Date:  1974-02       Impact factor: 3.765

View more
  20 in total

1.  The effects of clonidine on the partial reinforcement extinction effect (PREE).

Authors:  G Halevy; J Feldon; I Weiner
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Discontinuation of chronic clonidine treatment: evidence for facilitated brain noradrenergic neurotransmission.

Authors:  T H Svensson; U Strömbom
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-08       Impact factor: 3.000

3.  Effect of clonidine on ultrasonic vocalization in preweaning rats.

Authors:  E Hård; J Engel; A S Lindh
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

4.  Effect of the D1 receptor agonist SKF 38393 on some behavioural effects of apomorphine in rats.

Authors:  A M Zarkovsky; K S Cereska
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-04       Impact factor: 3.000

5.  Behavioral and biochemical studies of dopamine receptor sensitivity in differentially housed mice.

Authors:  C A Wilmot; C VanderWende; M T Spoerlein
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

6.  Modulation of motor activity by alpha 1- and alpha 2-adrenoceptor stimulation in mice.

Authors:  L Pichler; W Kobinger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-09       Impact factor: 3.000

7.  Locomotor activity of rats after stimulation of the nucleus locus coeruleus region or after lesion of the dorsal noradrenergic bundle: effects of clonidine, prazosin and yohimbine.

Authors:  L Velley; E Kempf; B Cardo
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

8.  Control of behaviour and brain noradrenaline neurons by peripheral blood volume receptors.

Authors:  B Persson; T H Svensson
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

9.  Clonidine-induced sedation in rats: evidence for mediation by postsynaptic alpha 2-adrenoreceptors.

Authors:  C Spyraki; H C Fibiger
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

10.  Behavioral responses to apomorphine and amphetamine in differentially housed mice.

Authors:  C A Wilmot; C Vander Wende; M T Spoerlein
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.